Cerave - 'Anti-Imperfections' Concentrate - 40 ml

Skin Type	Blemish-Prone Skin

Developed with dermatologists, Anti-Imperfection Concentrate is designed for acne-prone skin. It reduces pimples, blemishes, and tightens pores while restoring the skin barrier. Formulated with 3 essential ceramides and an AHA-BHA complex, as well as niacinamide and hyaluronic acid to hydrate and soothe the skin. The MVE technology ensures a prolonged diffusion of the active ingredients for continuous hydration.
The little extra: Its precision applicator makes it possible to deliver the right dose.
A complete daily treatment against imperfections enriched with 3 essential ceramides, Niacinamide, & Hyaluronic Acid, it moisturizes for 8 hours*, soothes and restores the skin barrier. Its fresh gel texture quickly penetrates the skin for a non-greasy, non-sticky effect. Its high tolerance formula, tested under dermatological control, respects a strict formulation charter to suit sensitive skin: fragrance-free, alcohol-free, hypoallergenic, physiological ph and non-comedogenic. Face formula, suitable for daily use by adolescents and adults.
*Instrumental test, measurement of hydration with a corneometer

This formula contains :
2% Salicylic Acid (BHA): Gently exfoliates, unclogs and tightens pores, smoothes skin texture while stimulating cell renewal.
AHAs (Glycolic and Lactic Acids): help remove dead skin cells and blemishes, even out skin texture while reducing inflammation.
Niacinamide: Gently soothes the skin, helps reduce feelings of irritation.
Hyaluronic acid: Helps maintain moisture
3 Essential Ceramides (1, 3, 6-II): help restore the skin barrier
MVE Technology: Continuously releases moisturising ingredients
Clinically proven effectiveness: -40% of pimples after 3 days of use**.
72% report fewer pimples***.
80% of patients say they are very satisfied with the product after 3 days.
90% said their skin was softer
78% reported smoother, more refined skin
**Clinical study in monotherapy, F&H, 13-45 years old, oily skin, acne-prone skin (light to moderate), 1 use per day on the face in the evening + 1 use of an SPF 30 cream in the morning. Measurement & clinical evaluation of inflammatory lesions at 3 days, 2, 4 and 8 weeks
*** Self-evaluation of patients after 3 days: 1 use per day on the face in the evening + 1 use of an SPF 30 cream in the morning